Skip to Content


In the US, Avastin (bevacizumab systemic) is a member of the drug class VEGF/VEGFR inhibitors and is used to treat Cervical Cancer, Colorectal Cancer, Fallopian Tube Cancer, Glioblastoma Multiforme, Non-Small Cell Lung Cancer, Ovarian Cancer, Peritoneal Cancer and Renal Cell Carcinoma.

US matches:

Ingredient matches for Avastin


Bevacizumab is reported as an ingredient of Avastin in the following countries:

  • Argentina
  • Armenia
  • Australia
  • Belgium
  • Bosnia & Herzegowina
  • Brazil
  • Canada
  • Chile
  • China
  • Colombia
  • Croatia (Hrvatska)
  • Cyprus
  • Czech Republic
  • Denmark
  • Ecuador
  • Egypt
  • Estonia
  • Finland
  • Georgia
  • Greece
  • Iceland
  • Ireland
  • Israel
  • Italy
  • Japan
  • Latvia
  • Lebanon
  • Lithuania
  • Macedonia
  • Mexico
  • Moldova
  • Myanmar
  • Netherlands
  • New Zealand
  • Norway
  • Paraguay
  • Peru
  • Philippines
  • Poland
  • Portugal
  • Romania
  • Russian Federation
  • Serbia
  • Slovenia
  • South Africa
  • Spain
  • Sweden
  • Taiwan
  • Thailand
  • United States
  • Uruguay
  • Vietnam

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.